Rheumatoid arthritis is a chronic autoimmune disease characterized by abnormal activation of the immune system, leading to persistent inflammatory responses in the joint synovium. This disease not only affects joint function but may also result in systemic tissue damage. The medical community currently believes that its etiology is the result of the interplay of multiple factors, including genetics, environment, and lifestyle, rather than a single cause.
Research shows that the erroneous attack by the autoimmune system is a key mechanism in the onset of the disease. Immune cells mistakenly identify joint tissues as foreign, releasing a large amount of inflammatory mediators, ultimately causing destructive changes in the joints. This process is closely related to genetic susceptibility, environmental triggers, and individual physiological states, forming a complex network of causation. Understanding these causes aids in early prevention and precise treatment.
The genetic background plays a fundamental role in the pathogenesis of rheumatoid arthritis. Studies have found that specific human leukocyte antigen (HLA) gene variants are highly associated with disease risk, among which the HLA-DR4 gene variant is considered the primary genetic marker. Individuals carrying this gene have a 2 to 3 times higher risk of developing the disease compared to the general population, indicating the critical influence of genetic predisposition on disease progression.
Twin studies show that if one identical twin is affected, the other has about a 15% chance of developing the disease, significantly higher than the 5% chance in fraternal twins. This evidence reinforces the critical role of genetic factors. Recent genomic studies have also found that non-HLA genes such as PTPN22, TRAF1-C5, and STAT4 are related to the disease mechanism, as these genes may regulate T cell function or inflammatory signaling pathways.
Environmental triggers can activate pathological responses in genetically susceptible individuals. Smoking is the most well-established environmental risk factor, as tar components in tobacco can induce activation of lung antigen-presenting cells, promoting the production of anti-citrullinated protein antibodies (ACPAs). Long-term smokers have a 2-4 times increased risk of developing the disease, and the severity of the condition correlates positively with the duration of smoking.
Body mass index (BMI) is positively correlated with disease risk, as adipose tissue in obese individuals continuously secretes inflammatory factors, potentially accelerating abnormal activation of the immune system. Studies show that for every 5-unit increase in BMI, the risk for female patients increases by 12%, while for males, it increases by 7%. This effect may be related to metabolic abnormalities of hormones such as leptin and resistin produced by adipose tissue.
Lack of regular exercise can lead to muscle atrophy around the joints, reducing joint stability, although insufficient exercise itself is not a direct cause of the disease. However, excessive joint use or injury may trigger local immune responses in susceptible individuals. In terms of diet, a high-sugar diet can promote the accumulation of AGEs (advanced glycation end products), potentially exacerbating joint tissue damage.
Gender differences are a significant epidemiological phenomenon, with the incidence rate in females being three times that of males, which is related to the mechanism by which estrogen regulates the immune system. Postmenopausal women face an increased risk of immune metabolic disorders due to hormonal changes. Regarding age, most patients develop the disease between the ages of 30 and 60, although cases of juvenile and elderly onset have also been reported.
Chronic stress may lead to metabolic disorders of corticosteroids through long-term abnormal activation of the hypothalamic-pituitary-adrenal axis. Studies indicate that individuals under prolonged high-stress conditions have elevated baseline levels of inflammatory factors such as IL-6 and TNF-α, which may lower the threshold of the immune system, promoting disease onset.
These multifaceted causes form a complex pathogenic network: genetic genes provide the pathological basis, environmental triggers disrupt immune balance, while lifestyle modulates the degree of risk. For example, smokers carrying susceptibility genes who are also in polluted environments may have a cumulative risk that is dozens of times higher than the influence of a single factor. This interaction mechanism explains why some patients exhibit typical symptoms while others present atypical disease courses.
The early symptoms of rheumatoid arthritis commonly include symmetrical swelling and pain in the small joints of the hands, accompanied by morning stiffness lasting more than half an hour. Unlike degenerative arthritis, rheumatoid arthritis is often accompanied by fatigue, low-grade fever, or slight weight loss, and rheumatoid factor or anti-CCP antibodies may be positive in the blood. If symptoms persist for more than two weeks, it is recommended to undergo immunological testing to differentiate the disease course.
How can one protect the joints in daily life to prevent worsening inflammation?It is recommended to adopt the principle of "saving the joints": using assistive devices to distribute joint load (such as long-handled grabbers), avoiding maintaining the same posture for extended periods, and distributing weight to larger muscle groups instead of small joints when lifting heavy objects. Heat therapy can relax stiff joints, but cold therapy should be used during acute inflammatory periods to reduce swelling.
Under what circumstances should the dosage of immunosuppressants be adjusted?When patients experience severe gastrointestinal discomfort, frequent infections, or abnormal blood cell counts, physicians may adjust the dosage of immunosuppressants or switch to different medications. The treatment goal is "relief-oriented," requiring regular monitoring of blood indices and imaging examinations, and adjusting the regimen based on inflammatory indices (such as C-reactive protein).
Can patients receiving biologic therapy be vaccinated?Patients undergoing immunomodulatory treatments such as biologics should avoid live virus vaccines (such as varicella and measles). Inactivated vaccines (such as influenza and pneumococcal vaccines) can be administered after physician evaluation, but it should be noted that vaccine efficacy may be reduced due to immune system suppression, and the timing of vaccination should align with the treatment cycle.
Does cold weather in winter exacerbate symptoms?Lower temperatures may induce discomfort due to vasoconstriction of the blood vessels around the joints and increased nerve sensitivity, but weather does not directly cause inflammation to worsen. It is recommended to maintain indoor temperatures, apply heat to affected joints, and continue regular exercise to maintain joint range of motion, avoiding stiffness caused by reduced activity due to cold.
%201.svg)
Copyright © 2025 MedFrontiers. All Rights Reserved.
